featured
Malignancy Risk Increased in Patients With Inflammatory Eye Disease Treated With Systemic Immunosuppressive Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ophthalmology